Sign in
Taking people in South KoreaNo phase

Compares a hemostatic agent with stitching during ovarian cyst surgery

Tests a bleeding-control agent against stitches in women with endometrioma cysts.

Key facts

Who runs it
Seoul National University Hospital
Where
Goyang-si and Seoul, South KoreaSee the 2 sites
Trial code
Registry title
Comparison of Hemostatic Agent to Suture in Terms of Hemostatic Function and Preservation of Ovarian Function
Status
Recruiting
People taking part
90 people, planned
Started
25 Feb 2021
Expected to end
31 Dec 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Hemostatic agent (EVICEL®) application during laparoscopic ovarian cystectomy
  • suturing with barbed sutures during laparoscopic ovarian cystectomy
Record updated
26 June 2023

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for women aged 19-45 who are planning keyhole (laparoscopic) surgery to remove ovarian cysts caused by endometriosis. It compares a hemostatic agent with stitches to stop bleeding.

Age
19-45 years
Sex
Women only
Disease stage
Endometriosis of the ovary (one or both ovaries), diagnosed by ultrasound, with laparoscopic ovarian cystectomy planned. ASA physical status 1 or 2.
Earlier treatment
No hormonal therapy within the last 3 months.
Biomarker or test result
Regular periods every 21-45 days. Serum Anti-mullerian hormone level must not be lower than 0.05 ng/ml.

Main reasons for not taking part

  • Suspected ovarian cancer
  • No ovarian endometriosis
  • Pregnant or breastfeeding
  • Anti-mullerian hormone level lower than 0.05 ng/ml
  • Hormonal therapy within the last 3 months

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Informed consent
  • Age: 19-45 year-old women
  • American Society of Anesthesiologists Physical Status classification 1 or 2
  • Plan of laparoscopic ovarian cystectomy for unilateral or bilateral ovarian endometriosis diagnosed by ultrasonography
  • Regular menstruation every 21-45 days

Who cannot take part

  • Hormonal therapy within recent 3 months
  • Suspicious disease of ovarian malignancy
  • Lower than 0.05 ng/ml of serum Anti-mullerian hormone level
  • Age: 18 and younger, 46 and older
  • No 'ovarian' endometriosis
  • Pregnancy or breastfeeding
  • Considered as inappropriate by the researcher's judgment

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 19 and 45 years old?

Where in South Korea

  • Dongguk University Ilsan HospitalGoyang-si, South KoreaContact: Ga Won Yim, MD/PhDNot yet recruiting
  • Seoul National University HospitalSeoul, South KoreaContact: Hyunji Lim, MDTaking people

About the trial

What the trial wants to find out

This study aims to evaluate the efficacy of preservation of ovarian function, hemostasis, and safety of a hemostatic agent versus suturing during laparoscopic ovarian cystectomy for ovarian endometriosis.

The 2 groups in the trial

  • Hemostatic agent groupTreatment being tested

    During laparoscopic ovarian cystectomy, bleeding will be controlled by using a hemostatic agent (EVICEL® Fibrin Sealant, Ethicon, USA), which consist of thrombin and coagulating proteins, mainly fibrinogen and fibronectin. If hemostasis is not fulfilled enough by using it, a additional intervention such as electrocoagulation with bipolar forceps and barbed suture is required to stop bleeding.

    Treatment: Hemostatic agent (EVICEL®) application during laparoscopic ovarian cystectomy

  • Suturing groupExisting treatment, for comparison

    During operation, barbed suture will be applied to the inner surface of ovarian parenchyme where ovarian endometriosis was attached. In this group, if bleeding is continued after suturing, additional electrocoagulation with bipolar forceps will be conducted.

    Treatment: suturing with barbed sutures during laparoscopic ovarian cystectomy

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Multi-center, Randomized, Investigator-initiated Trial to Evaluate the Efficacy of PRreservation of ovArian Function, Hemostasis, and sAfety of a Hemostatic Agent Versus Suturing During Laparoscopic Ovarian Cystectomy for Endometrioma
Plain-language title
Compares a hemostatic agent with stitching during ovarian cyst surgeryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT04643106, who can take part
Publications
Record updated
26 June 2023